(WRB) W. R. Berkley - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0844231029
Commercial Insurance, Reinsurance, Excess Lines, Specialty Products
Total Rating 52
Risk 25
Buy Signal -0.45
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.63% |
| Yield on Cost 5y | 7.46% |
| Yield CAGR 5y | -2.05% |
| Payout Consistency | 93.7% |
| Payout Ratio | 43.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 21.3% |
| Relative Tail Risk | -3.32% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.63 |
| Alpha | 10.07 |
| Character TTM | |
|---|---|
| Beta | 0.240 |
| Beta Downside | 0.154 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.96% |
| CAGR/Max DD | 0.83 |
Description: WRB W. R. Berkley December 17, 2025
W. R. Berkley Corp. (NYSE:WRB) is a global commercial-line insurer organized into two operating segments: Insurance, which underwrites a broad mix of admitted and excess-surplus lines-including casualty, property, specialty, cyber, and personal-lines products-and Reinsurance & Monoline Excess, which provides treaty and facultative reinsurance solutions across property-casualty and niche turnkey coverages.
Key metrics as of the latest filing (Q3 2024) show net written premiums of $7.2 billion, a combined ratio of 93.5 % (indicating underwriting profitability), and a return on equity (ROE) of 12.8 %-both above the industry median of roughly 90 % combined ratio and 10 % ROE. The segment’s performance is sensitive to macro-economic drivers such as U.S. commercial construction activity, corporate litigation trends, and the frequency of cyber events, which have been rising at an estimated 8 % CAGR over the past five years.
For a deeper dive into WRB’s valuation assumptions and how its risk-adjusted return compares to peers, you may find it useful to explore the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 1.91b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -0.97 > 1.0 |
| NWC/Revenue: 14.07% < 20% (prev 240.5%; Δ -226.5% < -1%) |
| CFO/TA 0.08 > 3% & CFO 3.40b > Net Income 1.91b |
| Net Debt (435.8m) to EBITDA (2.53b): 0.17 < 3 |
| Current Ratio: 4.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (400.2m) vs 12m ago -0.40% < -2% |
| Gross Margin: 20.98% > 18% (prev 0.23%; Δ 2075 % > 0.5%) |
| Asset Turnover: 34.86% > 50% (prev 32.69%; Δ 2.17% > 0%) |
| Interest Coverage Ratio: 14.83 > 6 (EBITDA TTM 2.53b / Interest Expense TTM 127.0m) |
Altman Z'' 2.00
| A: 0.05 (Total Current Assets 2.73b - Total Current Liabilities 668.7m) / Total Assets 43.72b |
| B: 0.30 (Retained Earnings 13.31b / Total Assets 43.72b) |
| C: 0.04 (EBIT TTM 1.88b / Avg Total Assets 42.04b) |
| D: 0.38 (Book Value of Equity 12.96b / Total Liabilities 33.91b) |
| Altman-Z'' Score: 2.00 = BBB |
Beneish M -0.63
| DSRI: 0.86 (Receivables 7.12b/7.43b, Revenue 14.65b/13.19b) |
| GMI: 1.08 (GM 20.98% / 22.72%) |
| AQI: 5.04 (AQ_t 0.93 / AQ_t-1 0.18) |
| SGI: 1.11 (Revenue 14.65b / 13.19b) |
| TATA: -0.03 (NI 1.91b - CFO 3.40b) / TA 43.72b) |
| Beneish M-Score: -0.63 (Cap -4..+1) = D |
What is the price of WRB shares?
As of January 29, 2026, the stock is trading at USD 67.67 with a total of 1,990,087 shares traded.
Over the past week, the price has changed by +0.19%, over one month by -4.41%, over three months by -5.31% and over the past year by +17.09%.
Over the past week, the price has changed by +0.19%, over one month by -4.41%, over three months by -5.31% and over the past year by +17.09%.
Is WRB a buy, sell or hold?
W. R. Berkley has received a consensus analysts rating of 3.56.
Therefor, it is recommend to hold WRB.
- StrongBuy: 5
- Buy: 1
- Hold: 8
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the WRB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 70.3 | 3.9% |
| Analysts Target Price | 70.3 | 3.9% |
| ValueRay Target Price | 75.8 | 12% |
WRB Fundamental Data Overview January 25, 2026
P/E Trailing = 14.1903
P/E Forward = 14.2248
P/S = 1.7406
P/B = 2.6186
P/EG = 10.1534
Revenue TTM = 14.65b USD
EBIT TTM = 1.88b USD
EBITDA TTM = 2.53b USD
Long Term Debt = 2.84b USD (from longTermDebt, last quarter)
Short Term Debt = 24.5m USD (from shortTermDebt, two quarters ago)
Debt = 2.84b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 435.8m USD (from netDebt column, last quarter)
Enterprise Value = 25.94b USD (25.51b + Debt 2.84b - CCE 2.40b)
Interest Coverage Ratio = 14.83 (Ebit TTM 1.88b / Interest Expense TTM 127.0m)
EV/FCF = 7.79x (Enterprise Value 25.94b / FCF TTM 3.33b)
FCF Yield = 12.84% (FCF TTM 3.33b / Enterprise Value 25.94b)
FCF Margin = 22.72% (FCF TTM 3.33b / Revenue TTM 14.65b)
Net Margin = 13.01% (Net Income TTM 1.91b / Revenue TTM 14.65b)
Gross Margin = 20.98% ((Revenue TTM 14.65b - Cost of Revenue TTM 11.58b) / Revenue TTM)
Gross Margin QoQ = 18.23% (prev 18.42%)
Tobins Q-Ratio = 0.59 (Enterprise Value 25.94b / Total Assets 43.72b)
Interest Expense / Debt = 1.12% (Interest Expense 31.8m / Debt 2.84b)
Taxrate = 21.01% (136.1m / 648.1m)
NOPAT = 1.49b (EBIT 1.88b * (1 - 21.01%))
Current Ratio = 4.08 (Total Current Assets 2.73b / Total Current Liabilities 668.7m)
Debt / Equity = 0.29 (Debt 2.84b / totalStockholderEquity, last quarter 9.80b)
Debt / EBITDA = 0.17 (Net Debt 435.8m / EBITDA 2.53b)
Debt / FCF = 0.13 (Net Debt 435.8m / FCF TTM 3.33b)
Total Stockholder Equity = 9.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.53% (Net Income 1.91b / Total Assets 43.72b)
RoE = 20.94% (Net Income TTM 1.91b / Total Stockholder Equity 9.10b)
RoCE = 15.78% (EBIT 1.88b / Capital Employed (Equity 9.10b + L.T.Debt 2.84b))
RoIC = 12.46% (NOPAT 1.49b / Invested Capital 11.94b)
WACC = 6.21% (E(25.51b)/V(28.35b) * Re(6.80%) + D(2.84b)/V(28.35b) * Rd(1.12%) * (1-Tc(0.21)))
Discount Rate = 6.80% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.78%
[DCF Debug] Terminal Value 86.34% ; FCFF base≈3.38b ; Y1≈3.85b ; Y5≈5.26b
Fair Price DCF = 367.9 (EV 140.25b - Net Debt 435.8m = Equity 139.82b / Shares 380.0m; r=6.21% [WACC]; 5y FCF grow 15.94% → 2.90% )
EPS Correlation: -41.39 | EPS CAGR: -47.24% | SUE: -4.0 | # QB: 0
Revenue Correlation: 95.18 | Revenue CAGR: 10.65% | SUE: 0.83 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.16 | Chg30d=-0.005 | Revisions Net=-6 | Analysts=15
EPS next Year (2026-12-31): EPS=4.61 | Chg30d=-0.021 | Revisions Net=-5 | Growth EPS=+7.5% | Growth Revenue=+5.3%
P/E Forward = 14.2248
P/S = 1.7406
P/B = 2.6186
P/EG = 10.1534
Revenue TTM = 14.65b USD
EBIT TTM = 1.88b USD
EBITDA TTM = 2.53b USD
Long Term Debt = 2.84b USD (from longTermDebt, last quarter)
Short Term Debt = 24.5m USD (from shortTermDebt, two quarters ago)
Debt = 2.84b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 435.8m USD (from netDebt column, last quarter)
Enterprise Value = 25.94b USD (25.51b + Debt 2.84b - CCE 2.40b)
Interest Coverage Ratio = 14.83 (Ebit TTM 1.88b / Interest Expense TTM 127.0m)
EV/FCF = 7.79x (Enterprise Value 25.94b / FCF TTM 3.33b)
FCF Yield = 12.84% (FCF TTM 3.33b / Enterprise Value 25.94b)
FCF Margin = 22.72% (FCF TTM 3.33b / Revenue TTM 14.65b)
Net Margin = 13.01% (Net Income TTM 1.91b / Revenue TTM 14.65b)
Gross Margin = 20.98% ((Revenue TTM 14.65b - Cost of Revenue TTM 11.58b) / Revenue TTM)
Gross Margin QoQ = 18.23% (prev 18.42%)
Tobins Q-Ratio = 0.59 (Enterprise Value 25.94b / Total Assets 43.72b)
Interest Expense / Debt = 1.12% (Interest Expense 31.8m / Debt 2.84b)
Taxrate = 21.01% (136.1m / 648.1m)
NOPAT = 1.49b (EBIT 1.88b * (1 - 21.01%))
Current Ratio = 4.08 (Total Current Assets 2.73b / Total Current Liabilities 668.7m)
Debt / Equity = 0.29 (Debt 2.84b / totalStockholderEquity, last quarter 9.80b)
Debt / EBITDA = 0.17 (Net Debt 435.8m / EBITDA 2.53b)
Debt / FCF = 0.13 (Net Debt 435.8m / FCF TTM 3.33b)
Total Stockholder Equity = 9.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.53% (Net Income 1.91b / Total Assets 43.72b)
RoE = 20.94% (Net Income TTM 1.91b / Total Stockholder Equity 9.10b)
RoCE = 15.78% (EBIT 1.88b / Capital Employed (Equity 9.10b + L.T.Debt 2.84b))
RoIC = 12.46% (NOPAT 1.49b / Invested Capital 11.94b)
WACC = 6.21% (E(25.51b)/V(28.35b) * Re(6.80%) + D(2.84b)/V(28.35b) * Rd(1.12%) * (1-Tc(0.21)))
Discount Rate = 6.80% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.78%
[DCF Debug] Terminal Value 86.34% ; FCFF base≈3.38b ; Y1≈3.85b ; Y5≈5.26b
Fair Price DCF = 367.9 (EV 140.25b - Net Debt 435.8m = Equity 139.82b / Shares 380.0m; r=6.21% [WACC]; 5y FCF grow 15.94% → 2.90% )
EPS Correlation: -41.39 | EPS CAGR: -47.24% | SUE: -4.0 | # QB: 0
Revenue Correlation: 95.18 | Revenue CAGR: 10.65% | SUE: 0.83 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.16 | Chg30d=-0.005 | Revisions Net=-6 | Analysts=15
EPS next Year (2026-12-31): EPS=4.61 | Chg30d=-0.021 | Revisions Net=-5 | Growth EPS=+7.5% | Growth Revenue=+5.3%